Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Retraction: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER.

Han D, Habte H, Qin Y, Takamoto K, LaBranche C, Montefiori D, Cho MW.

Retrovirology. 2014 Feb 6;11:16. doi: 10.1186/1742-4690-11-16. No abstract available.

PMID:
24502228
[PubMed - in process]
Free PMC Article
2.

Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines.

Ye L, Wen Z, Dong K, Wang X, Bu Z, Zhang H, Compans RW, Yang C.

PLoS One. 2011;6(5):e14813. doi: 10.1371/journal.pone.0014813. Epub 2011 May 19.

PMID:
21625584
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals.

Molinos-Albert LM, Carrillo J, Curriu M, Rodriguez de la Concepción ML, Marfil S, García E, Clotet B, Blanco J.

Retrovirology. 2014 Jun 7;11:44. doi: 10.1186/1742-4690-11-44.

PMID:
24909946
[PubMed - in process]
Free PMC Article
4.

Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment.

Luo M, Yuan F, Liu Y, Jiang S, Song X, Jiang P, Yin X, Ding M, Deng H.

Vaccine. 2006 Jan 23;24(4):435-42. Epub 2005 Aug 18.

PMID:
16143433
[PubMed - indexed for MEDLINE]
5.

Targeting HIV-1 gp41 in close proximity to the membrane using antibody and other molecules.

Gach JS, Leaman DP, Zwick MB.

Curr Top Med Chem. 2011 Dec;11(24):2997-3021. Review.

PMID:
22044228
[PubMed - indexed for MEDLINE]
6.

Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting.

Morris L, Chen X, Alam M, Tomaras G, Zhang R, Marshall DJ, Chen B, Parks R, Foulger A, Jaeger F, Donathan M, Bilska M, Gray ES, Abdool Karim SS, Kepler TB, Whitesides J, Montefiori D, Moody MA, Liao HX, Haynes BF.

PLoS One. 2011;6(9):e23532. doi: 10.1371/journal.pone.0023532. Epub 2011 Sep 30.

PMID:
21980336
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.

Nelson JD, Brunel FM, Jensen R, Crooks ET, Cardoso RM, Wang M, Hessell A, Wilson IA, Binley JM, Dawson PE, Burton DR, Zwick MB.

J Virol. 2007 Apr;81(8):4033-43. Epub 2007 Feb 7.

PMID:
17287272
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1.

Lai RP, Hock M, Radzimanowski J, Tonks P, Hulsik DL, Effantin G, Seilly DJ, Dreja H, Kliche A, Wagner R, Barnett SW, Tumba N, Morris L, LaBranche CC, Montefiori DC, Seaman MS, Heeney JL, Weissenhorn W.

J Biol Chem. 2014 Oct 24;289(43):29912-26. doi: 10.1074/jbc.M114.569566. Epub 2014 Aug 26.

PMID:
25160627
[PubMed - in process]
9.

Neutralizing epitopes in the membrane-proximal external region of HIV-1 gp41 are influenced by the transmembrane domain and the plasma membrane.

Montero M, Gulzar N, Klaric KA, Donald JE, Lepik C, Wu S, Tsai S, Julien JP, Hessell AJ, Wang S, Lu S, Burton DR, Pai EF, Degrado WF, Scott JK.

J Virol. 2012 Mar;86(6):2930-41. doi: 10.1128/JVI.06349-11. Epub 2012 Jan 11.

PMID:
22238313
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.

Zwick MB, Jensen R, Church S, Wang M, Stiegler G, Kunert R, Katinger H, Burton DR.

J Virol. 2005 Jan;79(2):1252-61.

PMID:
15613352
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Functional, non-clonal IgMa-restricted B cell receptor interactions with the HIV-1 envelope gp41 membrane proximal external region.

Verkoczy L, Moody MA, Holl TM, Bouton-Verville H, Scearce RM, Hutchinson J, Alam SM, Kelsoe G, Haynes BF.

PLoS One. 2009 Oct 6;4(10):e7215. doi: 10.1371/journal.pone.0007215.

PMID:
19806186
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

HIV-1 gp41 core with exposed membrane-proximal external region inducing broad HIV-1 neutralizing antibodies.

Wang J, Tong P, Lu L, Zhou L, Xu L, Jiang S, Chen YH.

PLoS One. 2011 Mar 31;6(3):e18233. doi: 10.1371/journal.pone.0018233.

PMID:
21483871
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Characterization of a trimeric MPER containing HIV-1 gp41 antigen.

Hinz A, Schoehn G, Quendler H, Hulsik DL, Stiegler G, Katinger H, Seaman MS, Montefiori D, Weissenhorn W.

Virology. 2009 Aug 1;390(2):221-7. doi: 10.1016/j.virol.2009.05.015. Epub 2009 Jun 18.

PMID:
19539967
[PubMed - indexed for MEDLINE]
Free Article
14.

Crystallographic definition of the epitope promiscuity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5: vaccine design implications.

Bryson S, Julien JP, Hynes RC, Pai EF.

J Virol. 2009 Nov;83(22):11862-75. doi: 10.1128/JVI.01604-09. Epub 2009 Sep 9.

PMID:
19740978
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Immunising with the transmembrane envelope proteins of different retroviruses including HIV-1: a comparative study.

Denner J.

Hum Vaccin Immunother. 2013 Mar;9(3):462-70. Epub 2012 Dec 18.

PMID:
23249763
[PubMed - in process]
Free PMC Article
16.

Modulation of nonneutralizing HIV-1 gp41 responses by an MHC-restricted TH epitope overlapping those of membrane proximal external region broadly neutralizing antibodies.

Zhang J, Alam SM, Bouton-Verville H, Chen Y, Newman A, Stewart S, Jaeger FH, Montefiori DC, Dennison SM, Haynes BF, Verkoczy L.

J Immunol. 2014 Feb 15;192(4):1693-706. doi: 10.4049/jimmunol.1302511. Epub 2014 Jan 24.

PMID:
24465011
[PubMed - indexed for MEDLINE]
17.

Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions.

Buzon V, Natrajan G, Schibli D, Campelo F, Kozlov MM, Weissenhorn W.

PLoS Pathog. 2010 May 6;6(5):e1000880. doi: 10.1371/journal.ppat.1000880.

PMID:
20463810
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Immunization with hybrid proteins containing the membrane proximal external region of HIV-1.

Strasz N, Morozov VA, Kreutzberger J, Keller M, Eschricht M, Denner J.

AIDS Res Hum Retroviruses. 2014 May;30(5):498-508. doi: 10.1089/AID.2013.0191. Epub 2014 Feb 7.

PMID:
24392780
[PubMed - in process]
19.

Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L.

Hessell AJ, Rakasz EG, Tehrani DM, Huber M, Weisgrau KL, Landucci G, Forthal DN, Koff WC, Poignard P, Watkins DI, Burton DR.

J Virol. 2010 Feb;84(3):1302-13. doi: 10.1128/JVI.01272-09. Epub 2009 Nov 11.

PMID:
19906907
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution.

Shen X, Dennison SM, Liu P, Gao F, Jaeger F, Montefiori DC, Verkoczy L, Haynes BF, Alam SM, Tomaras GD.

Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5972-7. doi: 10.1073/pnas.0912381107. Epub 2010 Mar 15.

PMID:
20231447
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk